Latest Articles

A recent study found that over one-third of men aged 15 years and over are infected with at least one type of HPV. In this article, we explore why HPV is not just a women's health issue.

In this article, we consider various platforms to modulate gene expression and the potential of CRISPR-Cas systems to understand and treat diseases, from cancers and congenital disorders to overcoming the growing prevalence of antimicrobial resistance.

This article explores why the traditional process of sorting through RWD is a challenge, what value is lost through that process, and the underlying technology needed to be able to filter and sort data in a compliant manner.

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.

Regulatory guidance relating to analytical procedures is in the process of changing to a lifecycle approach to ensure that procedures are suitable for intended use across all phases of the drug development life cycle.

Predatory conferences are the ramshackle distant cousin of your regular scientific event, a Fyre Festival of science (without the involvement of Ja Rule). It is getting harder to separate fake conferences from real ones. Given this deluge of dodgy science, we have created a guide to spotting and avoiding predatory conferences.

This article highlights recent developments in cryopreservation and the challenges that will need to be overcome to unleash the full potential of the technology.

Cryo electron microscopy (cryo EM) has revolutionized our understanding of the intricate molecular machinery that governs life. In this article, we discuss what cryo EM is, how it works, it's strengths, limitations and applications.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

This article explores how targeting the language of cancer cell communication could provide new ways to stop tumor growth and prevent drug resistance.